item management s discussion and analysis of financial condition and results of operations general atrion corporation is a holding company primarily engaged in the design  development  manufacturing  marketing  sale and distribution of proprietary products and components for the medical and healthcare industry 
the company s operations are conducted primarily by atrion medical products  halkey roberts and quest medical  all of which are wholly owned subsidiaries of the company 
atrion medical products and quest medical design  develop  manufacture  market  sell and distribute proprietary products for the medical and healthcare industry 
halkey roberts designs  develops  manufactures and sells proprietary medical device components and related components  all of which are used to control the flow of fluids and gases 
the company also owns two other subsidiaries which are small and incidental to the company s overall operations 
results of operations the company s income from continuing operations was million or per basic and per diluted share compared to income from continuing operations in of million or 
per basic and 
per diluted share and million or 
per basic and diluted share in net income  including discontinued operations  for totaled million or per basic and per diluted share compared with million or 
per basic and 
per diluted share in and million or 
per basic and diluted share in operating revenues were million in compared with million in and million in revenues increased in at all operations with one exception where unusually large product shipments in to a significant customer that was building up its inventory levels of our products impacted revenues 
the million increase in revenues from to was the result of improved sales at all operations and the inclusion of revenues of quest medical for twelve months in compared with the inclusion of quest medical revenues in for the eleven months subsequent to its acquisition in late january the company s cost of sales was million in compared with million in and million in the increase in cost of sales for over and for over was primarily related to the increased sales mentioned above and the impact of manufacturing volumes 
gross profits were million in compared with million in and million in the increase in gross profit in over was primarily the result of the above mentioned revenue increases 
the company s gross profit in was percent of revenues compared with percent of revenues in and percent of revenues in the increase in gross profit percentage in was primarily attributable to improved sales in certain higher margin products 
operating expenses were million in compared with million in and million in the decrease in operating expenses from to was primarily attributable to reduced general and administrative g a expenses and reduced research and development r d expenses 
g a expenses for were  lower than g a expenses for primarily as a result of lower spending on outside services  compensation and benefit programs 
r d expenses were  lower for as compared with this reduction is primarily the result of the company s reduced r d efforts on non core products with limited market potential 
the increase in operating expenses from to was primarily attributable to the expansion of marketing efforts associated with the mps product line 
the increase in operating expenses for over was also the result of the inclusion of the operation of quest medical for twelve months in compared with the inclusion of the quest medical operation in for the eleven months subsequent to its acquisition in late january the company s operating income for was million compared with million in and million in revenue growth during the three year period and cost containment and cost reduction activities  primarily in  contributed to the operating income improvements during the three year period 
net interest expense in was  compared with net interest expense of  in and net interest income in of  the change from to was primarily attributable to additional borrowings under the company s revolving credit facility to fund its repurchases of outstanding common stock of the company during and the change from to was primarily attributable to the company s use of cash and cash equivalents in late to fund repurchases of outstanding common stock of the company and in february to fund the purchase of its allen  texas facility and an increase in the company s borrowings to fund its repurchases of outstanding common stock of the company during net interest income in was primarily attributable to interest earned on the proceeds of the sale of the company s natural gas subsidiaries in may remaining after the late january purchase of the quest medical operation 
income tax expense in totaled  compared with  in and  in an increase in the company s foreign sales corporation benefit and an increase in the company s research and development tax credit resulted in a lower effective income tax rate for and compared with otherwise  the difference between years reflect changes in pretax income between the respective years 
the company believes that revenues at all operations will be higher than revenues at those operations and that the cost of goods sold  gross profit  operating income and income from continuing operations will be higher in than in the company is optimistic that its earnings per share from continuing operations will grow more than per year for the next three years 
discontinued operations as discussed in note in the notes to consolidated financial statements  on may   the company completed the sale of all of the issued and outstanding shares of common stock of alabama tennessee natural gas company  tennessee river intrastate gas company  inc and alatenn energy marketing company  inc 
for approximately million 
in the fourth quarter of  the company s two small remaining natural gas subsidiaries  central gas company and tennessee river development company  sold their assets for  the financial statements presented herein reflect the company s natural gas operations as discontinued operations for all periods presented 
the financial statements also reflect an after tax gain on disposal of discontinued operations of 
million or 
per basic and diluted share in  
million or 
per basic and diluted share in and 
million or 
per basic and diluted share in based upon the sale of the natural gas operations as described above 
liquidity and capital resources the company has an million revolving credit facility the credit facility with a regional bank to be utilized for the funding of operations and for major capital projects or acquisitions subject to certain limitations and restrictions see note of notes to consolidated financial statements 
borrowings under the credit facility bear interest that is payable monthly at day libor  day libor or day libor  as selected by the company  plus one percent 
at december  the company had million of outstanding borrowings under the credit facility 
at the company s option  and subject to certain conditions  the amount that can be borrowed under the credit facility may be increased to million upon the lender s determination that it has adequate security or upon the company s grant of such additional security as the lender deems reasonably necessary 
the term of the credit facility expires november  and may be extended under certain circumstances 
as of december   the company had cash and cash equivalents of  compared with  at december  the company had long term debt as of december  of million compared with million as of december  the increase in cash and cash equivalents from december  to december  and the decrease in long term debt from december  to december  was primarily funded by net cash from operating activities remaining after repurchases of outstanding common stock of the company and purchases of new machinery and equipment 
cash provided by continuing operations increased to million in compared to million in and million in capital expenditures for property  plant and equipment for continuing operations totaled million in compared with million in and million in included in the capital expenditure amount is million for the purchase of the allen  texas facility 
the company believes that its existing cash and cash equivalents  cash flows from operations  borrowings available under the company s credit facility and other equity or debt financing  which the company believes would be available  will be sufficient to fund the company s cash requirements for at least the foreseeable future 
in january  the board of directors discontinued the payment of quarterly cash dividends 
such action was taken to facilitate the company s growth strategy as well as to bring the company s dividend policy more in line with other companies in the medical products industry 
impact of inflation the company experiences the effects of inflation primarily in the prices it pays for labor  materials and services 
over the last three years  the company has experienced the effects of moderate inflation in these costs 
at times  the company has been able to offset a portion of these increased costs by increasing the sales prices of its products 
however  competitive pressures have not allowed for full recovery of these cost increases 
new accounting pronouncements see note in notes to consolidated financial statements 
forward looking statements the statements in this management s discussion and analysis and elsewhere in this annual report that are forward looking are based upon current expectations  and actual results may differ materially 
therefore  the inclusion of such forward looking information should not be regarded as a representation by the company that the objectives or plans of the company will be achieved 
such statements include  but are not limited to  the company s expectations regarding future revenues  cost of sales  gross profit  operating income  income from continuing operations  earnings per share from continuing operations  cash flows from operations  and availability of equity and debt financing 
words such as anticipates  believes  intends  expects and variations of such words and similar expressions are intended to identify such forward looking statements 
forward looking statements contained herein involve numerous risks and uncertainties  and there are a number of factors that could cause actual results to differ materially  including  but not limited to  the following changing economic  market and business conditions  the effects of governmental regulation  the impact of competition and new technologies  slower than anticipated introduction of new products or implementation of marketing strategies  implementation of new manufacturing processes or implementation of new information systems  changes in the prices of raw materials  changes in product mix  product recalls  the ability to attract and retain qualified personnel and the loss of any significant customers 
in addition  assumptions relating to budgeting  marketing  product development and other management decisions are subjective in many respects and thus susceptible to interpretations and periodic review which may cause the company to alter its marketing  capital expenditures or other budgets  which in turn may affect the company s results of operations and financial condition 
item a 
quantitative and qualitative disclosures about market risk interest rates the company has an million credit facility with a regional bank 
borrowings under the credit facility bear interest at day libor  day libor or day libor  as selected by the company  plus one percent 
the company is subject to interest rate risk based on an adverse change in the day libor  day libor or the day libor 
at december   the company had borrowings under the credit facility of million 
a one percent increase in the market interest rate would reduce the company s annual pretax income by approximately  at the current borrowing level 

